About Protometrix
Protometrix is a company based in Pittsburgh (United States) founded in 2001 was acquired by Invitrogen in March 2004. Protometrix operates in a competitive market with competitors including Inflammatix, Agendia, GenomeDx Biosciences, Affymetrix and Akonni, among others.
- Headquarter Pittsburgh, United States
- SectorsHealthcare
- Email••••••••
- Website protometrix.com
- Social LinkedIn X Facebook
- Acquired by Invitrogen (Mar 2004)
- InvestorsInvitrogen
& 1 more
- Acquired byInvitrogen
(Mar 2004)
Funding Insights of Protometrix
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Protometrix with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2001 | – | Seed | – | – |
2 investors in total: 2 institutional.
Investors in Protometrix
Protometrix has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Invitrogen and CHL Medical Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early stage healthcare services investments are facilitated by CHL. | – | chlmedical.com | Westport, United States | |
Provider of scientific instruments, services, and consumables | 1987 | invitrogen.com | Carlsbad, United States |
Investor details for Protometrix
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Protometrix
3 dated milestones of Protometrix across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Protometrix is founded.
- Funding First funding round.
- Exit Acquired by Invitrogen.
Competitors of Protometrix
Protometrix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inflammatix, Agendia, GenomeDx Biosciences, Affymetrix and Akonni, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| inflammatix.com | 2016 | San Francisco, United States | $191.47M | 54 | Provider of diagnostic solutions for systemic infections | |
| agendia.com | 2003 | Irvine, United States | $123M | 203 | Genomic diagnostic products for cancer treatment are provided. | |
| genomedx.com | 2008 | San Diego, United States | $69.75M | 159 | Genomic tests for urologic cancers are developed and commercialized. | |
| affymetrix.com | 1991 | Santa Clara, United States | – | 721 | Provider of technologies for multiplex and simultaneous analysis of biological systems at the cell, protein, and gene level | |
| akonni.com | 2003 | Frederick, United States | $39.75M | 12 | Molecular diagnostics for complex infections are developed by Akonni. | |
| kromatid.com | 2007 | Fort Collins, United States | $14.54M | – | Molecular and genetic tests for detecting disease-causing mutations are provided. | |
| indevr.com | 2003 | Boulder, United States | $16M | – | Biotherapeutics, vaccines, and diagnostic products are manufactured and developed. | |
| pamgene.com | 1999 | Virginia, United States | $17.89M | – | PamGene is focused on kinome-based biomarkers for drug development and therapy. | |
| synplogen.com | 2017 | Tsuruoka, Japan | – | – | DNA synthesis technology is developed using microbial methods. | |
| exiqon.com | 1995 | Vedbaek, Denmark | $22.9M | 65 | LNA-based tools are developed for diagnostics and research applications. |
Detailed competitors of Protometrix
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Protometrix
10 companies that operate in the same segment as Protometrix (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Protometrix
Protometrix was founded in 2001.
Protometrix is headquartered in Pittsburgh, United States. It is registered at Pittsburgh, Pennsylvania, United States.
Protometrix is a biotechnology company dedicated to the development and application of proprietary integrated proteomics technologies to improve human health. Its technologies are based on the pioneering protein microarray work of Professor Michael Snyder of Yale University. The core capabilities of the company include both production and investigation of the function and interaction of thousands of proteins in parallel using nanoscale technology and collection of all of the information in a state-of-the-art informatics database. In addition, this database is a valuable predictor that provides direction in experimental design. Its technology allows definition and study of proteomes (the comprehensive complement of proteins produced by an organism) of any species for the first time. In Feb 2004, the company was acquired by Invitrogen (now part of Thermo Fisher).
Protometrix's top competitors include Inflammatix, Agendia and KromaTiD.
Protometrix has 2 investors. Key investors include Invitrogen, and CHL Medical Partners.
Yes. Protometrix was acquired by Invitrogen in March 2004.